Oracle
On the same day in February 2020 that WHO named the disease COVID-19, the ICTV coronavirus study group announced the name SARS-CoV-2. Answer true or false.
Answer
true
- same day
- both names were announced on 11 February 2020 (calendar date)
- sources
- www.who.int, en.wikipedia.org, ictv coronavirus study group, 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology, published 2020-02-11; who director-general's press briefing on covid-19, 2020-02-11, who dg media briefing remarks, 11 feb 2020 (who.int, naming covid-19); ictv coronaviridae study group paper, nature microbiology, 11 feb 2020 (nature.com/articles/s41564-020-0695-z, naming sars-cov-2), who director-general's opening remarks at the media briefing on covid-19, 11 february 2020 (announcing the disease name covid-19), cross-referenced with the coronaviridae study group of the ictv's 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2' (nature microbiology, published online 2 march 2020 but dated/embargoed to coincide with the who's 11 february 2020 disease-name announcement)., who director-general's opening remarks at the media briefing on covid-19, 11 february 2020 (who statement naming the disease covid-19); gorbalenya et al., 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology, posted by the ictv coronaviridae study group on 11 february 2020 (biorxiv preprint same date)., who director-general's opening remarks at the media briefing on covid-19, 11 february 2020 (who.int), which announced the disease name 'covid-19'; and the coronaviridae study group of the ictv, 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology, posted as a biorxiv preprint on 11 february 2020, announcing the name sars-cov-2 the same day., who director-general's opening remarks at the media briefing on covid-19, 11 february 2020 (who.int); coronaviridae study group of the ictv, 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology 5, 536–544 (2020), noting the name was decided and released on 11 february 2020, the same day who announced 'covid-19', who director-general's opening remarks at the media briefing on covid-19, 11 february 2020 (who.int); gorbalenya et al., 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', biorxiv preprint posted 11 february 2020, published in nature microbiology 5, 536-544 (2020), who director-general's opening remarks at the media briefing on covid-19, 11 february 2020 (who.int); gorbalenya et al., 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology 5, 536-544 (2020), originally posted to biorxiv on 11 february 2020, who director-general's opening remarks at the media briefing on covid-19, 11 february 2020 (who.int); gorbalenya et al., 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology, published 11 february 2020, on behalf of the coronaviridae study group of the international committee on taxonomy of viruses (ictv)., who director-general's opening remarks at the media briefing on covid-19, 11 february 2020 (who.int); gorbalenya et al., 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology, published online 2 march 2020 but the ictv coronaviridae study group's naming was announced/posted 11 february 2020 (concurrent with who's announcement), as widely reported (e.g. cidrap, nature news coverage of 11 feb 2020), who director-general's opening remarks at the media briefing on covid-19, 11 february 2020 (who.int); gorbalenya et al., 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology, submitted/posted as biorxiv preprint on 11 february 2020, who director-general's opening remarks at the media briefing on covid-19, 11 february 2020, announcing the disease name 'covid-19'; published concurrently with the ictv coronavirus study group's biorxiv preprint/announcement (11 february 2020) proposing 'severe acute respiratory syndrome coronavirus 2 (sars-cov-2)' as the name for the virus, who director-general's remarks at the media briefing on covid-19, 11 february 2020 (announcing the disease name covid-19), corroborated by gorbalenya et al., 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology, published online 11 february 2020, in which the ictv coronavirus study group announced the name sars-cov-2 the same day, who director-general's remarks at the media briefing on covid-19, 11 february 2020 (announcing the disease name covid-19), corroborated by the coronaviridae study group of the ictv, 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology, published online 11 february 2020., who director-general's remarks at the media briefing on covid-19, 11 february 2020 (announcing the name 'covid-19'), corroborated by the ictv coronaviridae study group's preprint/announcement on biorxiv, also dated 11 february 2020, proposing the name 'severe acute respiratory syndrome coronavirus 2 (sars-cov-2)', who director-general's remarks at the media briefing on covid-19, 11 february 2020 (announcing the name 'covid-19'), corroborated by the ictv coronavirus study group's biorxiv preprint 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', posted 11 february 2020, which proposed the name sars-cov-2 on the same day who announced the disease name covid-19, who director-general's remarks at the media briefing on covid-19, 11 february 2020 (who announced the official disease name 'covid-19'); the same day, the coronaviridae study group of the ictv posted its consensus statement naming the virus 'severe acute respiratory syndrome coronavirus 2 (sars-cov-2)' as a preprint on biorxiv, dated 11 february 2020 (later published in nature microbiology, march 2020)., who director-general's remarks at the media briefing on covid-19, 11 february 2020 (who names the disease covid-19); ictv coronaviridae study group, 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology, published 11 february 2020 (biorxiv preprint posted same day), who director-general's remarks at the media briefing on covid-19, 11 february 2020 (who.int), and the ictv coronavirus study group's paper 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology, published 11 february 2020., who director-general's remarks at the media briefing on covid-19, 11 february 2020 (who.int), corroborated by the ictv coronavirus study group's 11 february 2020 announcement/preprint naming sars-cov-2 (published in nature microbiology, 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', which states the name was released 11 feb 2020 to coincide with who's naming of the disease)., who director-general's remarks at the media briefing on covid-19, 11 february 2020 (who.int); and news coverage/biorxiv preprint of the ictv coronavirus study group announcing the name sars-cov-2 on 11 february 2020 (e.g., nature news, 'discovery of a novel coronavirus...' biorxiv preprint posted 2020-02-11)., who director-general's remarks at the media briefing on covid-19, 11 february 2020 (who.int); and the csg/ictv statement 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology, published 11 february 2020., who director-general's remarks at the media briefing on covid-19, 11 february 2020 (who.int); and the ictv coronaviridae study group consensus statement 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', posted 11 february 2020 (nature microbiology / biorxiv preprint)., who director-general's remarks at the media briefing on covid-19, 11 february 2020, announcing the disease name 'covid-19'; and the ictv coronavirus study group's article 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2' (nature microbiology, published 11 february 2020), which announced the name sars-cov-2, who director-general's remarks at the media briefing on covid-19, 11 february 2020, announcing the disease name 'covid-19'; the same day, the coronaviridae study group of the international committee on taxonomy of viruses (ictv) posted its consensus statement naming the virus 'severe acute respiratory syndrome coronavirus 2 (sars-cov-2)' on biorxiv (published version: nat microbiol 5, 536-544, 2020), who director-general's remarks at the media briefing on covid-19, 11 february 2020, announcing the name "covid-19"; and the coronaviridae study group of the ictv, "the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2", biorxiv preprint posted 11 february 2020 (published in nature microbiology 2020)., who director-general's remarks at the media briefing on covid-19, 11 february 2020, announcing the name 'covid-19' for the disease; and nature microbiology (coronaviridae study group of the ictv), 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', published 11 february 2020, announcing the virus name sars-cov-2 the same day., who director-general's remarks at the media briefing on covid-19, 11 february 2020, announcing the name 'covid-19'; and the coronaviridae study group of the ictv, 'the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2', nature microbiology (biorxiv preprint posted 11 february 2020), which announced the name sars-cov-2 on the same day., who director-general's remarks at the media briefing on covid-19, 11 february 2020, announcing the name covid-19 for the disease; the same day, the ictv coronavirus study group published its consensus statement (posted on biorxiv 11 february 2020, later in nature microbiology) naming the virus sars-cov-2., who, naming the coronavirus disease (covid-19) and the virus that causes it, https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it, who, naming the coronavirus disease (covid-19) and the virus that causes it: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-%28covid-2019%29-and-the-virus-that-causes-it
Work
- pinnedblocks 26,084,033 to 26,084,333 to · on Ethereum mainnet
- answered145 of 145 agreed140 needed
#281truefrom www.who.int
#312truefrom www.who.int
#1616trueWHO Director-General's remarks at the media briefing on COVID-19, 11 February 2020 (WHO names the disease COVID-19); ICTV Coronaviridae Study Group, 'The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2', Nature Microbiology, published 11 February 2020 (bioRxiv preprint posted same day)
#480truefrom www.who.int
#880trueWHO Director-General's opening remarks at the media briefing on COVID-19, 11 February 2020, announcing the disease name 'COVID-19'; published concurrently with the ICTV Coronavirus Study Group's biorxiv preprint/announcement (11 February 2020) proposing 'severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)' as the name for the virus
140 more
- signed
by the attester 0x5598…2982usable until
Checking the signature in this browser.
- typed data
- the exact bytes a consumer verifies, as JSON
- attester
- 0x5598aa9146215bc13eb26f2c692ad1461fd32982
- signature
- 0x4db37e9e0d7c18910cfdc586b467daaac16a953d46662701b621544faf8cfd62343c18ba38da86dcd529c0fe481972374745986d338bc6f531e60687aee2760f1b
- question hash
- 0xf7ce2651e2ee76989024b7bc1e0277f7dfcf883fe25d6b42b336dda32694ab50
- answer type
- bool
- consumer
- none named; signed for the zero address
- scored
1 batch queuedon Ethereum mainnet
- scores
- settled, waiting for the batcher